OPN expression inhibitor 1

• UNSPSC Description:

  OPN expression inhibitor 1 (Compound 11) is an osteopontin (OPN) expression inhibitor. OPN expression inhibitor 1 can be used for breast cancer research[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/opn-expression-inhibitor-1.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  [H][C@@]12CC[C@]3(OO[C@]14[C@@H](O3)OC([C@@H]([C@@]4(CC[C@H]2C)[H])C)OCC5=CN(N=N5)CC6=CC=CC=C6)C

• Molecular Weight:

  455.55

• References & Citations:

  [1]Pasupuleti BG, et al. 1,2,3-Triazole tethered 1,2,4-trioxanes: Studies on their synthesis and effect on osteopontin expression in MDA-MB-435 breast cancer cells. Eur J Med Chem. 2020 Jan 15;186:111908.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2257492-95-6